Medline (MDLN) Non-Current Assets (2024 - 2026)

Medline (MDLN) has reported Non-Current Assets for 3 consecutive years, with $27.6 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Assets changed N/A year-over-year to $27.6 billion in Q2 2026; TTM through Jun 2026 was $111.0 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $27.8 billion, changed 0.36% from the prior year.
• Non-Current Assets was $27.6 billion for Q2 2026 at Medline, down from $27.8 billion in the prior quarter.
• Over five years, Non-Current Assets peaked at $27.8 billion in Q1 2026 and troughed at $27.6 billion in Q2 2026.
• A 3-year average of $27.7 billion and a median of $27.8 billion in 2024 frame the typical range for Non-Current Assets.
• The widest YoY moves for Non-Current Assets: up 0.36% in 2025, down 0.36% in 2025.
• Over 3 years, Non-Current Assets stood at $27.7 billion in 2024, then increased by 0.36% to $27.8 billion in 2025, then decreased by 0.71% to $27.6 billion in 2026.
• The last three Non-Current Assets figures came in at $27.6 billion (Q2 2026), $27.8 billion (Q1 2026), and $27.8 billion (Q4 2025), per Business Quant data.